World Heart Corporatio WHRT announced today that it will cease its efforts to commercialize the Levacor ventricular assist device technology and will focus its resources on developing and commercializing its smaller, next-generation MiFlow VAD.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in